Overview: Malaria Parasite QBC TestIntroduction: The Malaria Parasite QBC Test detects malaria parasites via quantitative buffy coat (QBC) to diagnose malaria, causing fever or chills. Aligned with 2023 WHO guidelines, it uses microscopy for high specificity, supporting parasite screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in parasitology for patients with suspected malaria.
Other Names: Malaria QBC Assay, Quantitative Buffy Coat Test.
FDA Status: Laboratory-developed test (LDT), meeting parasitology standards for diagnostic accuracy.
Historical Milestone: QBC testing for malaria began in the 1980s with parasitology research. Fluorescence-based microscopy improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects malaria parasites via QBC to diagnose malaria, guides treatment, and evaluates patients with fever or chills.
Test Parameters: 1. Malaria Parasite (QBC)
Pretest Condition: No fasting required. Collect whole blood. Report history of fever, chills, or travel to malaria-endemic areas.
Specimen: Whole Blood (EDTA, 2-5 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document fever, chills, fatigue, or travel history to malaria-endemic areas. Include current medications, especially antimalarials.
Consent: Written consent required, detailing the tests purpose, malaria implications, and risks of blood collection.
Procedural Considerations: Uses QBC microscopy to detect malaria parasites in whole blood. Results are available in 1-2 days, supporting rapid clinical decisions. Performed in laboratories, often for malaria diagnosis.
Factors Affecting Result Accuracy: Improper sample storage or low parasite load can affect results. Contamination may reduce specificity.
Clinical Significance: Positive QBC results confirm malaria, guiding antimalarial therapy. Negative results may require microscopy or PCR.
Specialist Consultation: Consult an infectious disease specialist for result interpretation and treatment planning.
Additional Supporting Tests: Malaria antigen test, microscopy, or PCR to confirm malaria diagnosis.
Test Limitations: Sensitivity depends on parasite load; clinical correlation is needed. QBC may miss low-density infections.
References: WHO Malaria Guidelines, 2023; The Lancet Infectious Diseases, White NJ, 2022.
